Please wait...
Rubicon Publications
Home >> Publish book chapter >> Contemporary Pharmacology in Drug Action, Toxicology and Translational Research (Volume - 1)

Publish a Book Chapter in "Contemporary Pharmacology in Drug Action, Toxicology and Translational Research (Volume - 1)"

Call for Book Chapters: Submissions Now Open

978-1-80433-857-5

Pharmacology Edited Book | Edited Book on Pharmacology


This edited book on pharmacology titled "Contemporary Pharmacology in Drug Action, Toxicology and Translational Research" mainly focuses on various topics such as receptor pharmacology, signal transduction, dose–response curves etc., and the rest are given below in the Scope of the book. This pharmacology edited book will be published with ISBN numbers after following a proper double blind peer reviewed process. All the chapters of this pharmacology edited book will be published in a proper style, so that reader can easily understand and learn.

Author can download this pharmacology edited book titled "Contemporary Pharmacology in Drug Action, Toxicology and Translational Research" authorship responsibility and copyright form: Click Here

Indexed In


Indexed in Crossref Indexed in Dimensions Indexed in Bowker
Invited Topics

  1. Inflammation Pathways and Anti-Inflammatory Drug Mechanisms
  2. Endocrine Pharmacology and Metabolic Target Modulation
  3. Pharmacogenomics and Precision Medicine in Clinical Pharmacology
  4. Genetic Polymorphisms Influencing Drug Response and Toxicity
  5. Precision Dosing Strategies in Pediatrics and Geriatrics
  6. Therapeutic Drug Monitoring and Individualized Exposure Targets
  7. Translational Endpoints and Bridging Biomarkers Across Species
  8. Toxicology Foundations for Modern Pharmacology Research
  9. Toxicodynamics and Mechanistic Understanding of Toxic Effects
  10. Hepatotoxicity Mechanisms, Biomarkers, and Risk Mitigation
  11. Nephrotoxicity Mechanisms and Renal Safety Assessment
  12. Neurotoxicity Assessment and Translational Relevance
  13. Cardiotoxicity Beyond QT: Structural and Functional Injury
  14. Reproductive and Developmental Toxicology in Translational Contexts
  15. Genotoxicity Testing and Interpretation for Risk Assessment
  16. Immunotoxicity and Hypersensitivity Reactions: Mechanisms and Models
  17. Predictive Toxicology Using In Vitro and In Silico Approaches
  18. Adverse Outcome Pathways and Mechanistic Risk Frameworks
  19. Organ-on-Chip Systems and Microphysiological Models in Pharmacology
  20. Organoids for Modeling Drug Efficacy and Toxicity
  21. Selecting Animal Models for Translational Pharmacology Studies
  22. Designing Translational Studies with Improved External Validity
  23. Exposure–Response Modeling for Safety Margin Determination
  24. Safety Biomarkers and Their Qualification for Clinical Use
  25. Human-Relevant In Vitro Metabolism Models and DDI Prediction
  26. Computational Pharmacology and Mechanistic Modeling Tools
  27. Drug Repurposing: Pharmacological Rationale and Evidence Standards
  28. Translational Pharmacology in Oncology: Targets and Resistance
  29. Immuno-Oncology Pharmacology and Combination Therapy Strategies
  30. Antimicrobial Pharmacology and PK/PD for Resistance Suppression
  31. Antiviral Pharmacology and Emerging Infection Therapeutics
  32. Respiratory Pharmacology and Drug Delivery to the Lung
  33. Gastrointestinal Pharmacology and Microbiome–Drug Interactions
  34. Dermatological Pharmacology and Topical Drug Action Mechanisms
  35. Pain Pharmacology and Mechanisms of Analgesic Drugs
  36. Addiction Pharmacology and Neurobiological Targets
  37. Sedatives, Anesthetics, and Mechanisms of CNS Depression
  38. Hematology Pharmacology and Anticoagulant Drug Actions
  39. Thrombosis Pharmacology and Antiplatelet Therapy Mechanisms
  40. Metabolic Pharmacology and Obesity Drug Targets
  41. Diabetes Pharmacology and Novel Antihyperglycemic Agents
  42. Pharmacology of Hypertension: Pathways and Drug Choices
  43. Heart Failure Pharmacology and Neurohormonal Modulation
  44. Pharmacology of Autoimmune Diseases and Biologic Therapies
  45. Safety Pharmacology Study Design and Regulatory Expectations
  46. First-in-Human Dose Selection and Translational Safety Strategies
  47. Phase 0 and Microdosing Studies in Translational Pharmacology
  48. Model-Informed Drug Development from a Pharmacology Perspective
  49. Clinical Trial Pharmacology and Exposure–Response Analyses
  50. Pharmacometric Approaches for Special Populations
  51. Drug Formulation Effects on Pharmacokinetics and Therapeutic Response
  52. Bioequivalence and Biowaivers: Pharmacological Considerations
  53. Therapeutic Index, Benefit–Risk, and Clinical Decision Making
  54. Post-Marketing Pharmacology and Real-World Safety Signals
  55. Adverse Drug Reactions and Mechanistic Classification
  56. Toxicity Mitigation Through Dose Adjustment and Monitoring Plans
  57. Drug–Herb Interactions and Translational Safety Implications
  58. Environmental Toxicology and Drug Residues: Pharmacological View
  59. Laboratory Methods in Receptor Binding and Functional Assays
  60. Electrophysiology Methods for Ion Channel Drug Testing
  61. Imaging Biomarkers in Pharmacology and Target Engagement
  62. Translational Biomarkers in Neuroscience Drug Development
  63. Pharmacology of Vaccines and Immune Response Modulation
  64. Systems Approaches to Polypharmacology and Off-Target Effects
  65. Network Toxicology and Identifying Toxicity Pathways
  66. Data Standards and Reporting Quality in Pharmacology Research
  67. Reproducibility and Experimental Rigor in Translational Pharmacology
  68. Ethics and Animal Welfare in Pharmacology Experiments
  69. Regulatory Science and Translational Pharmacology Alignment
  70. Integrating Pharmacology with Clinical Guidelines and Therapeutic Use
  71. Personalized Medicine Case Studies from Pharmacology to Practice
  72. Pharmacology Education Innovations for Translational Competence
  73. Big Data and Real-World Evidence in Pharmacology Decision Making
  74. Artificial Intelligence for Mechanism Discovery and Safety Prediction
  75. Future Directions in Systems and Translational Pharmacology
  76. Bridging Preclinical Findings to Human Outcomes: Best Practices
  77. Managing Uncertainty in Translational Pharmacology Programs
  78. Case Studies in Drug Action and Toxicology Investigations
  79. Research Gaps in Contemporary Pharmacology and Toxicology
  80. Roadmap for Next-Generation Translational Pharmacology Research
Book Scope

  • Receptor Pharmacology
  • Signal Transduction
  • Dose–Response Curves
  • PK/PD Basics
  • Pharmacodynamics Models
  • Therapeutic Index
  • Drug Metabolism
  • CYP Enzymes
  • Transporter Biology
  • Drug Interactions
  • Systems Pharmacology
  • Network Models
  • Biomarkers in PK/PD
  • Translational Endpoints
  • Mechanism of Action
  • Target Engagement
  • Allosteric Modulation
  • Biased Agonism
  • Ion Channels
  • GPCR Signaling
  • CNS Pharmacology
  • Cardiovascular Pharmacology
  • Immunopharmacology
  • Inflammation Pathways
  • Endocrine Pharmacology
  • Pharmacogenomics
  • Precision Dosing
  • Toxicodynamics
  • Organ Toxicity
  • Hepatotoxicity
  • Nephrotoxicity
  • Cardiotoxicity
  • Neurotoxicity
  • QT Prolongation
  • Genotoxicity
  • Reproductive Toxicology
  • Immunotoxicity
  • In Vitro Models
  • Organoids Use
  • Animal Model Choice
  • Translational Modeling
  • PBPK Modeling
  • Safety Biomarkers
  • Predictive Toxicology
  • Adverse Outcome Pathways
  • Clinical Translation
  • First-in-Human Doses
  • Therapeutic Monitoring
  • Drug Repurposing
  • Reporting Standards


Author Guidelines

To download guidelines: Click here


Submit Chapter

To submit chapter: Click here

OR

Send your chapter on rubiconpublications@gmail.com



Deadline

31 Jan 2026